⌘K
Loading ticker…
AstraZeneca PLC · Healthcare · Pharmaceutical Products
As of 2026-06-26, AstraZeneca PLC (AZN) has a 3-month relative strength percentile of 46 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 76. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 1.7%, relative volume 1.64×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
46 is not yet a leadership-grade RS read, Market Stance is 47
Daily range, ATR, beta, and the math for a 1-ADR stop.
AZN is in a stage 2 uptrend, week 1. Currently in a 90-day base; basing ADR 1.7% (broad 1.7%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 1.8% / 34.9%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
AZN appears in 1 ETF as of Mar 2026: FVD at 0.45% weight, $36M notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| FVDFirst Trust Value Line Dividend Index Fund | 0.45% | $36M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AZN Jan avg: 1.07% median: -0.07% win: 50% σ: 4.97% n: 4 2022-04-12 → 2026-05-29 | AZN Feb avg: 32.10% median: 3.71% win: 50% σ: 61.92% n: 4 2022-04-12 → 2026-05-29 | AZN Mar avg: 0.78% median: 1.02% win: 50% σ: 6.13% n: 4 2022-04-12 → 2026-05-29 | AZN Apr avg: 0.84% median: -2.33% win: 40% σ: 7.70% n: 5 2022-04-12 → 2026-05-29 | AZN May avg: 0.66% median: 0.12% win: 60% σ: 1.48% n: 5 2022-04-12 → 2026-05-29 | AZN Jun avg: -1.69% median: -1.34% win: 0% σ: 1.79% n: 4 2022-04-12 → 2026-05-29 (current) | AZN Jul avg: 1.63% median: 0.86% win: 100% σ: 2.07% n: 4 2022-04-12 → 2026-05-29 | AZN Aug avg: 2.20% median: 1.95% win: 50% σ: 9.04% n: 4 2022-04-12 → 2026-05-29 | AZN Sep avg: -6.82% median: -7.53% win: 0% σ: 5.73% n: 4 2022-04-12 → 2026-05-29 | AZN Oct avg: -0.17% median: 0.30% win: 50% σ: 8.69% n: 4 2022-04-12 → 2026-05-29 | AZN Nov avg: 6.32% median: 7.34% win: 75% σ: 9.47% n: 4 2022-04-12 → 2026-05-29 | AZN Dec avg: 0.02% median: -0.55% win: 25% σ: 3.09% n: 4 2022-04-12 → 2026-05-29 |